The Philips Healthcare Stellarex drug-coated balloon (DCB). It is cleared for use in peripheral vessels and treatment of failing AV access.

Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels. They also have been investigated in clinical trials to prevent coronary artery in-stent restenosis. 

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s U.S. pivotal trial of its novel CLAAS device, a next-generation transcatheter left atrial appendage (LAA) closure occluder for patients with atrial fibrillation (AF). LAA occlusion allows AFib patients to go off of life-long anticoagulation therapy.

August 5, 2020 – Minneapolis-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve repair technology, announced it has closed on its Series A financing led by a non-disclosed strategic investor together with healthcare specialist investor Hadean Ventures and Investinor. The $18.5 million in financing will fund its first-in-human feasibility trial.   

August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a multi-phase pilot project using the pinpointIQ solution to manage patients with heart failure and patients undergoing ileostomy. These patient populations historically have significant clinical risks when transitioning from the hospital to home.

Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella

August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for the use of Abiomed Impella left ventricular (LV) support systems to providing temporary LV unloading and support to treat critical  coronavirus (COVID‐19) patients who are already on extracorporeal membrane oxygenation (ECMO) treatment. 

August 4, 2020 — Imaging software company TomTec has released its new TomTec-Arena 2020 product, which offers new advances in echocardiography though intelligent automation and web-based diagnostic workflows. 

August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF  investigational device exemption (IDE) study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation (PAF). The study will evaluate the performance of the investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) for people whose atrial fibrillation (AFib) symptoms are unable to be managed by medication.

August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in healing heart attack scars, the European Heart Journal publishing some surprising results showing that the heart cell treatment does benefit patients.[1]

Data from the ALLSTAR study published Tuesday by the European Heart Journal showed that although infusions of allogeneic cardiac cells (called cardiosphere-derived cells or CDCs) did not appear to shrink the infarct scar after a heart attack, other data from the study show a clear benefit. 

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77 percent survival rate at 30 days in acute myocardial infarction (AMI) cardiogenic shock patients. The historic survival rate for cardiogenic shock is approximately 50 percent. 

Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of July 2020. This is based on the website’s 264,954 pageviews for the month. 

1. The Cardiovascular Impact of COVID-19
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now